Add to ORKGFor many patients with acute myeloid leukemia (AML), allogeneic hematopoietic cell transplantation (HCT) from a matched related donor provides the best, and sometimes the only, chance for long-term survival. However, only ap
Postremission therapy in patients with acute myeloid leukemia (AML) may consist of continuing chemot...
Background: Acute myeloid leukemia (AML) is both more common and with more biologically aggressive p...
Secondary AML (s-AML), including AML with an antecedent hematologic disorder (AHD-AML) and therapy-r...
Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative therapy for adult...
Although hematopoietic stem cell transplantation (HSCT) from HLA-matched siblings has become treat-m...
The optimal treatment approach to patients with acute myeloid leukemia (AML) who relapse after an al...
Clinical outcomes after allogeneic hematopoietic stem cell transplantation (allo-SCT) from unrelated...
Outcomes after matched unrelated donor vs. identical sibling hematopoietic cell transplantation (HCT...
International audienceSecondary acute myeloid leukemia (sAML) traditionally has inferior outcomes co...
Background: Primary refractory acute myeloid leukemia (PRF-AML) is associated with a dismal prognosi...
Allogeneic hematopoietic stem cell transplantation (alloHSCT) remains the treatment of choice to con...
AbstractAllogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) and myel...
We compared transplants (HSCT) from matched related siblings (MSD) with those from matched 10/10 and...
Hematopoietic cell transplantation (HCT) from a matched related donor (MRD) benefits many adults wit...
AbstractThe use of alternative donor transplants is increasing as the transplantation-eligible popul...
Postremission therapy in patients with acute myeloid leukemia (AML) may consist of continuing chemot...
Background: Acute myeloid leukemia (AML) is both more common and with more biologically aggressive p...
Secondary AML (s-AML), including AML with an antecedent hematologic disorder (AHD-AML) and therapy-r...
Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative therapy for adult...
Although hematopoietic stem cell transplantation (HSCT) from HLA-matched siblings has become treat-m...
The optimal treatment approach to patients with acute myeloid leukemia (AML) who relapse after an al...
Clinical outcomes after allogeneic hematopoietic stem cell transplantation (allo-SCT) from unrelated...
Outcomes after matched unrelated donor vs. identical sibling hematopoietic cell transplantation (HCT...
International audienceSecondary acute myeloid leukemia (sAML) traditionally has inferior outcomes co...
Background: Primary refractory acute myeloid leukemia (PRF-AML) is associated with a dismal prognosi...
Allogeneic hematopoietic stem cell transplantation (alloHSCT) remains the treatment of choice to con...
AbstractAllogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) and myel...
We compared transplants (HSCT) from matched related siblings (MSD) with those from matched 10/10 and...
Hematopoietic cell transplantation (HCT) from a matched related donor (MRD) benefits many adults wit...
AbstractThe use of alternative donor transplants is increasing as the transplantation-eligible popul...
Postremission therapy in patients with acute myeloid leukemia (AML) may consist of continuing chemot...
Background: Acute myeloid leukemia (AML) is both more common and with more biologically aggressive p...
Secondary AML (s-AML), including AML with an antecedent hematologic disorder (AHD-AML) and therapy-r...